This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Dehaier Medical Receives Software Copyrights For Four Proprietary Technologies

Stocks in this article: DHRM





BEIJING, July 12, 2012 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it has obtained software copyrights from the National Copyright Administration of PRC for four of its proprietary technologies, including:

(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO )

  • Analysis and Monitoring Software of Adsorption Tower Oxygen Generation Process;
  • Dehaier Homecare CPAP Controlling Software;
  • Ventilator of CPAP Controlling Software; and
  • Air Compressor Controlling Software.

These copyrights have been approved for 50 years.  In addition to providing the Company protection in the event of infringement, the software copyright registration is essential to the Company's identification as a "software enterprise" or a "high-technology enterprise." These statuses are important to Dehaier, as they allow the Company to receive preferential government treatment, such as subsidies and tax benefits. 

Mr. Ping Chen, CEO of Dehaier, commented, "We continue to focus on developing quality homecare medical devices, which rely on precise IT and software applications that Dehaier develops internally.  These copyrights are important in protecting the technology that Dehaier is developing, especially as we introduce more products to market.  We also expect to benefit from the favorable policies and subsidies from China's government as a result of our treatment as a hi-tech enterprise.  With the addition of these copyrights, we have two utility model patents, four design patents and nine software copyrights.  We will continue to protect our intellectual property portfolio in unison with strengthening our R&D capabilities, increasing our brand recognition, and gaining market share."



About Dehaier Medical Systems Ltd.

Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD ( Italy), Welch Allyn ( USA), HEYER ( Germany), Timesco (UK), eVent Medical (US) and JMS ( Japan). Dehaier's technology is based on six patents, nine software copyrights and proprietary technology. More information may be found at http://www.dehaier.com.cn



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,262.01 +70.64 0.41%
S&P 500 2,001.30 -0.86 -0.04%
NASDAQ 4,627.2820 -10.7120 -0.23%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs